TherapeuticsMD (TXMD) Receivables (2010 - 2025)
TherapeuticsMD's (TXMD) quarterly Receivables came in at $20.8 million in Q4 2025, down 10.25% YoY from $23.1 million in Q4 2024, and down 10.25% on a QoQ basis from $23.1 million in Q4 2024.
TherapeuticsMD (TXMD) Receivables (2010 - 2025) Analysis & Trends
TherapeuticsMD (TXMD) has 16 years of Receivables data on file, last reported at $20.8 million in Q4 2025.
- Quarterly Receivables fell 10.25% year-over-year to $20.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.8 million (down 10.25% YoY) and the FY2025 annual result came in at $20.8 million, down 10.25% from the prior year.
- Receivables retreated to $20.8 million in Q4 2025, from $23.1 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $45.8 million in Q2 2022 to a low of $20.8 million in Q4 2025.
- A 5-year average of $32.3 million and a median of $33.6 million in 2021 frame the typical range for Receivables.
- Annual changes were most pronounced in 2021 — Receivables surged 83.05% — and 2022, when it retreated 14.02%.
- Tracing TXMD's Receivables over 5 years: stood at $36.2 million in 2021, then declined by 11.11% to $32.2 million in 2022, then retreated by 23.3% to $24.7 million in 2023, then retreated by 6.2% to $23.1 million in 2024, then retreated by 10.25% to $20.8 million in 2025.
- The last three Receivables figures came in at $20.8 million (Q4 2025), $23.1 million (Q4 2024), and $24.7 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.27 Bn | 43.31 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.51 Bn | 39.86 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 32.62 Bn | 30.94 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.87 Bn | 17.99 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 1.08 Bn |
| 10 | TherapeuticsMD | 23.96 Mn | 14.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.76 Mn |
| Dec 31, 2024 | 23.13 Mn |
| Dec 31, 2023 | 24.66 Mn |
| Sep 30, 2022 | 32.16 Mn |
| Jun 30, 2022 | 45.80 Mn |
| Mar 31, 2022 | 35.41 Mn |
| Dec 31, 2021 | 36.18 Mn |
| Sep 30, 2021 | 37.40 Mn |
| Jun 30, 2021 | 33.48 Mn |
| Mar 31, 2021 | 33.72 Mn |
| Dec 31, 2020 | 32.38 Mn |
| Sep 30, 2020 | 24.06 Mn |
| Jun 30, 2020 | 18.29 Mn |
| Mar 31, 2020 | 20.66 Mn |
| Dec 31, 2019 | 24.40 Mn |
| Sep 30, 2019 | 15.32 Mn |
| Jun 30, 2019 | 18.38 Mn |
| Mar 31, 2019 | 14.94 Mn |
| Dec 31, 2018 | 11.06 Mn |
| Sep 30, 2018 | 12.80 Mn |